Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology

Gumusay, Ozge; Coskun, Ugur; AKMAN, Tulay; EKINCI, Ahmet; Kocar, Muharrem; ERCELEB, Ozlem; YAZICI, Ozan; Kaplan, Mehmet; Berk, Veli; Cetin, Bulent; Taskoylu, Burcu; Yildiz, Ayhan; Goksel, Gamze; Alacacioglu, Ahmet; DEMIRCI, Umut; Algin, Efnan; Uysal, Mukremin; Oztop, Ilhan; OKSUZOGLU, Berna; Dane, Faysal; Gumus, MAHMUT; Buyukberber, Suleyman

doi:10.1007/s00432-013-1553-7

Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology

Gumusay O., Coskun U., AKMAN T., EKINCI A. S. , Kocar M., ERCELEB O. B. , ...More

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.140, no.1, pp.151-157, 2014 (Peer-Reviewed Journal)

Publication Type: Article / Article
Volume: 140 Issue: 1
Publication Date: 2014
Doi Number: 10.1007/s00432-013-1553-7
Journal Name: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded, Scopus
Page Numbers: pp.151-157

Abstract

The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of < 6 months. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10-40 %. Our aim was to identify factors predicting development of BMs and survival.